Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 585, doi. 10.1007/s40259-013-0045-2
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2013 AND VI 27 AND IP 6
Results: 8
1
2
Alpha-1 Antitrypsin Deficiency: New Developments in Augmentation and Other Therapies.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 547, doi. 10.1007/s40259-013-0042-5
- By:
- Publication type:
- Article
3
Sorafenib and Thyroid Cancer.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 615, doi. 10.1007/s40259-013-0049-y
- By:
- Publication type:
- Article
4
Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 591, doi. 10.1007/s40259-013-0048-z
- By:
- Publication type:
- Article
5
Therapeutic Potential of Targeting Interleukin 5 in Asthma.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 559, doi. 10.1007/s40259-013-0047-0
- By:
- Publication type:
- Article
6
Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 565, doi. 10.1007/s40259-013-0046-1
- By:
- Publication type:
- Article
7
Acknowledgement to Referees.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 545, doi. 10.1007/s40259-013-0075-9
- Publication type:
- Article
8
Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 605, doi. 10.1007/s40259-013-0050-5
- By:
- Publication type:
- Article